Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
AIDS (London, England)|June 21, 2021
HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activityKazuo Suzuki, Angelique Levert, Julie Yeung, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonistsTakao Kiyoi, Julia M Adam, John K Clark, et al.Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonistsRonald Palin, David R Barn, John K Clark, et al.The Journal of Physical Chemistry. A|October 19, 2016
Direct Measurements of Unimolecular and Bimolecular Reaction Kinetics of the Criegee Intermediate (CH<sub>3</sub>)<sub>2</sub>COORabi Chhantyal-Pun, Oliver Welz, John D Savee, et al.The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part IKevin S Thorneloe, Anthony C Sulpizio, Zuojun Lin, et al.Journal of Clinical Immunology|September 17, 2018
Gastric Cancer Screening in Common Variable ImmunodeficiencyDavid K van der Poorten, Duncan McLeod, Golo Ahlenstiel, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2011
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidatePaul Ratcliffe, Julia M Adam, James Baker, et al.Pageof 5